Watanabe G, Takai Y, Nagane Y, Kubota T, Yasuda M, Akamine H, Onishi Y, Uzawa A, Kawaguchi N, Masuda M, et al. Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis. Front Immunol. 2024. 15. 150272
Uchi T†, Konno S†, Kihara H†, Sugimoto T†. Successful Control of Myasthenic Crisis After the Introduction of Ravulizumab in Myasthenia Gravis: A Case Report. Cureus. 2024. DOI: 10.7759/cureus.74117
Uchi T†, Konno S†, Kihara H†, Sugimoto H†. Unveiling the Masked Culprit: Central Nervous System Infection With Varicella-Zoster Virus Diagnosed by Multiplex PCR in an Elderly Patient With Atypical Neurological Symptoms. Cureus. 2024. DOI:. 10.7759/cureus.71631
Sugimoto T, Suzuki S, Uzawa A, Yamawaki T, Masuda M, Minami N, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, et al. Worsening of myasthenic symptoms associated with statins. J Neurol Sci. 2024. 464. 123154
Konno S†, Uchi T†, Kihara H†, Sugimoto H†. Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application. Healthcare (Basel). 2024. DOI:. 10.3390/healthcare12171793